Depsipeptides TRIZ Cases

Fusion proteins combine recombinant hemagglutinin with fluorescent markers to target L-rhamnose or D-galactose, enabling precise microbial and tumor imaging.

Hybrid fHBP constructs integrate multiple antigen families to resolve cross-strain protection limitations in serogroup B vaccines.

Modified HSP and HYP promoters increase carotenoid production by resolving low expression levels in Yarrowia biosynthesis.

Reversible MHC multimers use chelate bonds to isolate antigen-specific CD8+ T-cells without inducing activation-dependent cell death.

Novel N-terminal fusion partner stabilizes target polypeptides via inclusion body formation, preventing protease degradation and boosting yield.

Recombinant yeast strain produces lactic acid via lactate dehydrogenase expression, eliminating neutralizing agent consumption.

A bicycle drug conjugate delivers cytotoxic payloads to tumor cells via high-affinity peptide binding.

Oxidized alpha1-acid glycoprotein binds to hydrazide supports.

Acetal intermediates stabilize unstable aldehydes, improving yield and purity in macrocyclic depsipeptide synthesis.

Chimeric polypeptides merge endoglucanase, cellobiohydrolase, and beta-glucosidase activities into a single molecule to degrade cellulose.

An N-terminal PDI tag prevents aggregation during E. coli expression, maintaining biological activity without denaturants.

Styrene maleic acid copolymers form lipid-protein complexes that retain native conformation during chromatographic separation.

Engineered hybrid ribosomal promoters combine nucleotide sequences from Bacillus species to drive protein expression in host microorganisms.

Engineered fluorescent proteins increase maturation speed at mammalian cell temperatures via specific amino acid substitutions, resolving low speed limitations.

Solid phase peptide synthesis assembles linear gram-positive bacteriocins with in situ disulfide bond formation.

Heterologous cysteine exporter proteins relieve growth inhibition by L-cysteine, enabling higher productivity in fermentation processes.

Genetically modified extracts remove reducing enzymes to enable oxidizing conditions, resolving aggregation issues during protein folding.

Ligase couples fragments in water, suppressing hydrolysis and racemization for high purity.

A two-step refolding method uses sulfobetaine solubilization and ion exchange removal to produce biologically active granulocyte colony stimulating factor.

Segmenting the alk operon reduces metabolic burden and by-product formation while maintaining high-density fermentation performance.

Replacing unstable busulfan standards with a stable amide derivative prevents decomposition and ensures accurate quantification of drug levels.

Membrane proteins extract fucosyllactose from host cells to prevent cytotoxicity and boost yield.

Spontaneous ester bonds enable stable multimeric protein complexes while allowing reversible hydrolysis for dynamic structural reconfiguration.

Recombinant glycosylated proBNP replaces unstable synthetic BNP-32 to resolve peptide degradation issues in immunoassay calibration.

A Nec transporter protein facilitates human milk oligosaccharide efflux from genetically modified cells.

A pyruvate optical sensor fuses a detection polypeptide with a fluorescent protein to quantify analyte levels.

Engineered E. coli replaces costly in vitro peptide synthesis with aerobic biological assembly, enabling scalable production of conductive nanowires.

Segmented p120 and p140 epitopes replace whole-cell lysates to eliminate cross-reactivity in Ehrlichia chaffeensis diagnosis.

Knockout of the endogenous 7α-HSDH gene in E. coli BL21(DE3) host cells to produce pure recombinant enzymes.

A 20G7 monoclonal antibody targets the F11GRKMDR17 epitope to detect BNP(1-32).

Increasing evgA, gadE, or ydeO gene expression in modified Enterobacteriaceae resolves low productivity bottlenecks by enhancing L-amino acid accumulation.

Segmented breeding creates uniform inbred lines to resolve genetic non-uniformity in hybrid corn development.

Targeting intracellular RyR2 channels normalizes calcium homeostasis, avoiding pro-arrhythmic effects from traditional ion channel modulation.

Magnetic barcode beads conjugated with viral proteins resolve the sensitivity-versus-multiplexing trade-off in SARS-CoV-2 antibody detection.

A chimeric fusion protein combines non-human chaperone domains with human FKBP sequences to enhance folding helper activities.

Electron spin-labeled ice binding compounds distribute paramagnetic centers in frozen water solutions to enable dynamic nuclear polarization.

Over-expressing the dicarboxylic acid transporter boosts Mucor circinelloides oil yield, addressing unstable plant-based gamma-linolenic acid production.

Peptidomimetic macrocycles stabilize alpha helices to antagonize beta-catenin/TCF interactions, resolving toxicity from overlapping binding surfaces.

Variant Fc domain monomers extend serum half-life via neonatal Fc receptor binding, reducing administration frequency and side effects.

TBG 29 celery cultivar maintains high yield under fusarium pressure by altering vernalization thresholds to prevent bolting.

The pCS1 promoter maintains strong transcription across growth rates, resolving yield drops during slow fed-batch phases.

Co-expressing chaperones and foldases prevents intermolecular aggregation, enabling efficient protein secretion in filamentous fungi.

A decoy peptide mimics phosphorylated phospholamban to competitively inhibit protein phosphatase 1 activity.

BAHD acyltransferase enzymes incorporate monolignol ester conjugates into lignin to ease degradation for biofuel processing.

Mutated Cys4p and Yap1p in yeast increase glutathione concentration while reducing gamma-glutamylcysteine intermediates.

Novel peptides capture antibodies in non-human primate blood samples, resolving low diagnostic sensitivity and specificity that cause false negative results.

Signal peptides target CRM197 to the periplasm, resolving low yields and improper folding in E. coli expression systems.

Engineered Invasin polypeptides boost integrin binding affinity by up to 1000-fold, overcoming low transit efficiency across the gut epithelium.

Ideal mixing minimizes aggregation to increase biologically active protein yield.